| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |